The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of colon cancer (CC) molecular signatures with prognosis and oxaliplatin prediction-benefit in the MOSAIC Trial (Multicenter International Study of Oxaliplatin/5FU-LV in the Adjuvant Treatment of Colon Cancer).
 
Katherine L. Pogue-Geile
Patents, Royalties, Other Intellectual Property - The following patent was submitted: U. S. Patent Application Serial No. 14/738,757, entitled: “Methods of Subtyping CRC and their Association with Treatment of Colon Cancer Patients with Oxaliplatin." Published 12/24/15.
 
Thierry Andre
Honoraria - AMGEN; Bayer; Bristol-Myers Squibb; PRMA Consulting; Roche/Genentech; Sanofi; SERVIER; Xbiotech
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Guardant Health; HalioDX; MSD Oncology; Mundipharma; Roche/Genentech; SERVIER
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD Oncology; MSD Oncology; Roche/Genentech
 
Nan Song
Patents, Royalties, Other Intellectual Property - The following patent was filed Patent Application Serial No. 14/738,757 entitled “Methods of Subtyping CRC and their Association with Treatment of Colon Cancer Patients with Oxaliplatin and published on 12/24/15
 
Corey Lipchik
No Relationships to Disclose
 
Ying Wang
No Relationships to Disclose
 
Rim S. Kim
No Relationships to Disclose
 
Huichen Feng
No Relationships to Disclose
 
Patrick Gavin
No Relationships to Disclose
 
Jean-Luc Van Laethem
No Relationships to Disclose
 
Ashok Srinivasan
No Relationships to Disclose
 
Tamas Hickish
Employment - IQ Health Tech
Leadership - IQ Health Tech
Consulting or Advisory Role - Lilly; SOBI
Research Funding - Lilly; Pfizer; Roche
Patents, Royalties, Other Intellectual Property - Bournemouth University
 
Samuel A. Jacobs
No Relationships to Disclose
 
Josep Tabernero
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Bayer; BeiGene; Biocartis; Boehringer Ingelheim; Chugai Pharma; Foundation Medicine; Genentech; Genmab; HalioDx; Halozyme; Imugene; Inflection Biosciences; Ipsen; Kura Oncology; Lilly; Menarini; Merck Serono; Merrimack; Merus; Molecular Partners; MSD; Novartis; Peptomyc; Pfizer; Pharmacyclics; ProteoDesign; Rafael Pharmaceuticals; Roche; Roche; Sanofi; Seagen; Seagen; Servier; Symphogen; Taiho Pharmaceutical; VCN Biosciences
 
Peter C. Lucas
Stock and Other Ownership Interests - Amgen
Consulting or Advisory Role - Bayer (I)
 
Aimery De Gramont
Honoraria - Chugai Pharma; Yakult Pharmaceutical
 
Norman Wolmark
No Relationships to Disclose
 
Jean-François Flejou
No Relationships to Disclose
 
Soonmyung Paik
No Relationships to Disclose